Our Funds

OUR FUNDS

The END Fund manages a portfolio of programmatic funds to advance our vision to ensure that people at risk of NTDs have the opportunity to live healthy and prosperous lives. Currently, the END Fund offers three funds as investment opportunities for private philanthropists, foundations, corporations and others.

FLAGSHIP FUND

Mission –To use an adaptable and holistic approach that ensures no population is left behind, and those with the greatest need or living in countries with the greatest burden of neglected diseases have access to treatment for the five most common NTDs.

Vision– To ensure the most neglected people have access to treatment to live healthy lives.

DEWORMING INNOVATION FUND

Mission –To use innovation to dramatically reduce the public health burden caused by parasitic worm infections – intestinal worms and schistosomiasis.

Vision– To accelerate sustained improvements to the overall health and wellbeing of communities by rewriting the disease elimination playbook for parasitic worm infections.

REACHING THE LAST MILE FUND

Mission –To pave the way to end two devastating neglected tropical diseases (NTDs) – river blindness and lymphatic filariasis (LF).

Vision– To fast track the effort to eliminate river blindness and LF to end these diseases for good.

Blog

Our Funds

The END Fund manages a portfolio of programmatic funds to advance our vision to ensure that people at risk of NTDs have the opportunity to live healthy and prosperous lives. Currently, the END Fund offers three funds as investment opportunities for private philanthropists, foundations, corporations and others. Flagship Fund Deworming Innovation Fund Reaching the Last…

The Story of Daniel Shungu

Daniel Shungu first came to the United States in 1962 from the Democratic Republic of Congo. His plan was not to stay in America for the rest of his life, but to get an education and return to the DRC with skills that would help people in his country. However, his life plan changed and…

In pictures: Launch of IDA Drug Therapy Pilot Program in Kenya

In a historic moment, the Kenyan Ministry of Health piloted a new drug therapy for lymphatic filariasis in November 2018. IDA (ivermectin, diethylcarbamazine, albendazole) treatment has the potential to reduce the time to treat and break transmission of lymphatic filariasis (LF) from at least five years down to just two years. Globally, 892 million people…

The individual impact of 5 years of school-based deworming

In 2013, the END Fund was still new to the community of organizations working on neglected tropical diseases (NTDs). Only officially founded in 2012, our goal was (and still is) to raise private capital in order to help fill the gaps in NTD programs focussing on countries in Africa. By 2013, we were expanding to…